SMAD7 is a novel independent predictor of survival in patients with cutaneous melanoma.
Transl Res
; 204: 72-81, 2019 02.
Article
en En
| MEDLINE
| ID: mdl-30342000
Palabras clave
IHCâ¯=â¯immunohistochemistry; IRSâ¯=â¯immunoreactive score; MSSâ¯=â¯melanoma-specific survival; RFSâ¯=â¯recurrence-free survival; SLNBâ¯=â¯sentinel lymph node biopsy; TGFßRâ¯=â¯transforming growth factor ß receptor; TGFßâ¯=â¯transforming growth factor ß; TILsâ¯=â¯tumor infiltrating lymphocytes
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias Cutáneas
/
Proteína smad7
/
Melanoma
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Transl Res
Asunto de la revista:
MEDICINA
/
TECNICAS E PROCEDIMENTOS DE LABORATORIO
Año:
2019
Tipo del documento:
Article